This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Zai Lab Ltd. (Chinese biopharmaceutical company) raised $30mm in its Series C financing round. The round was led by OrbiMed along with additional new investors Vivo Capital, Cormorant, and Rock Springs Capital. The company will use the offering proceeds to fund its R&D and for future partnering. Back in 2016, Zai raised a large B round at $100mm.
Already a Biomedtracker subscriber?You have access to the full deal record through your subscription
Want to become a subscriber?Subscribers get more deal details, updates, deal financials and deal products.Questions?